MANNKIND CORP - 10-Q Filing

MannKind Corp reports Q3 2025 financial results including updates on Blackstone credit facility and United Therapeutics license agreements.

SEC EDGAR ·

Tickers: $MNKD

Read the full article at SEC EDGAR

More Regulatory news